Biodermol Ambiente

What Biodermol Ambiente does

Biodermol Ambiente is an Italian biotechnology company founded in 2013 and headquartered in Lavis, Italy. According to its firmographic profile, the company develops enzymatic formulations and chemical auxiliaries targeted at two distinct end-use domains: skin treatment and water treatment. The company operates as a private, for-profit entity with a reported headcount of 11–50 employees, placing it in the small/mid-tier band of European specialty chemical and biotechnology firms. Its operating geographies, customer base, distribution model, and ownership structure are not documented in the captured source set, and its corporate website (biodermol.it) was not retrievable beyond a loading/verification interstitial in the present crawl, leaving most firm-level pages inaccessible.

The company's product offering spans two separate vertical applications—personal-care/skin treatment and industrial/environmental water treatment—which suggests either a shared underlying biocatalyst/enzyme platform reused across verticals or two semi-independent product lines that share a formulation and manufacturing base. Beyond the high-level category descriptor ("enzymatic formulations and chemical auxiliaries"), the input set does not disclose specific active ingredients, proprietary process technology, certifications, regulatory approvals (e.g., cosmetic, biocidal, or water-treatment approvals under EU REACH/BPR), or platform architecture. There are no captured patents, trademarks, product-launch records, partnerships, customer logos, or select-customer references in the data; consequently the company's technical differentiation, regulatory standing, and competitive positioning cannot be independently verified from the provided material.

From a business-model standpoint, no pricing structure, distribution channels, sales motion, revenue mechanics, or segment-level economics are disclosed. Whether Biodermol Ambiente operates as a B2B specialty-chemical supplier, a contract/formulation manufacturer, a private-label/brand seller, or some hybrid is not evident in the captured data. The company has no disclosed funding rounds, no listed investors, no captured executive roster, no public ticker (private), and no revenue, ARR, GMV, or valuation figures available in the input. Source coverage of the firm is sparse: the only explicitly attributable source ID in the data set pertains to a non-existent API/integration surface, rather than to substantive product, financial, or organizational disclosures.

Name

Biodermol Ambiente

Website

https://biodermol.it

Company type

Private

Founded year

2013

Headcount range

11–50 employees

Short description

Biodermol Ambiente is an Italian biotechnology company, founded in 2013 in Lavis, that develops enzymatic formulations and chemical auxiliaries for skin treatment and water treatment applications, operating as a privately held firm with 11–50 employees.

Ownership category

akta.pro rank

Product category

Specialty Biotechnology / Industrial Enzymes

NAICS

Chemical Manufacturing (325)

SIC

Miscellaneous Chemical Products (2890)

akta.pro primary industry

Bio-based Surfactants, Detergent Ingredients & Oleochemicals (EUAAAIAE)

akta.pro secondary industry

Biocides & Disinfection Chemicals (Non-Agricultural) (IMAEAJAL)

Keywords

• Enzymatic formulations
• Chemical auxiliaries
• Skin treatment solutions
• Water treatment chemicals
• Industrial biotechnology

Headquarters

HQ city

Lavis

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Core offering

Biodermol Ambiente is a biotechnology company that develops and supplies enzymatic formulations and chemical auxiliaries. Its product portfolio targets two application areas: skin treatment (likely for cosmetic/personal-care formulators) and water treatment (likely for industrial/municipal water processing). The company manufactures and sells its own biochemical formulations rather than operating as a distributor or service provider.

Differentiator

Problem solved

Functional benefit

Products and services

• Enzymatic Formulations for Skin Treatment
• Enzymatic Formulations for Water Treatment
• Chemical Auxiliaries

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial solutions with a substantial personal-care and water-treatment enzyme portfolio; directly comparable as a much larger incumbent in the same enzymatic formulation space as Biodermol.
• Evonik Industries: Diversified specialty chemicals company with a life-sciences division producing cosmetic actives, biocides, and water-treatment specialties; comparable broad-incumbent peer.
• IFF (DuPont Nutrition & Biosciences): Major specialty ingredient and enzyme producer via its DuPont heritage, serving personal care and industrial bioscience markets; broadly comparable to Biodermol's enzymatic formulation focus at vastly larger scale.
• DSM-firmenich: Global specialty ingredients company with significant personal-care, cosmetic actives, and water-treatment chemistry portfolios; comparable as a larger incumbent serving the same downstream customers as Biodermol.
• Clariant: Swiss specialty chemicals producer with industrial and consumer-care segments including surfactants, biocides, and bio-based auxiliaries; comparable as a larger specialty-chemical peer.
• BASF Care Chemicals: World's largest chemical company with a Care Chemicals division producing personal-care ingredients and water-treatment auxiliaries; broadly comparable incumbent in Biodermol's served end markets.

Direct peers

• AB Enzymes: Specialty enzyme manufacturer focused on industrial applications including detergents and cleaning - a direct competitor in the enzymatic formulation category for water/surface treatment.
• Solabia Group: French specialty ingredient maker offering biotech-derived cosmetic actives and bio-industrial solutions; a closely comparable mid-sized peer also selling enzymatic/bio-based formulations into personal-care and industrial customers.

Emerging players

• Bio-Fed (a branch of FKuR): European developer of bio-based and biodegradable specialty formulations for industrial applications; comparable emerging peer in the bio-based formulation space with overlap to Biodermol's enzymatic chemistry focus.
• Stellarchem: Specialty chemical manufacturer and distributor focused on water treatment, personal care, and industrial intermediates - an emerging/regional peer with comparable product breadth in similar end markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/Biodermol
• Facebookfacebook.com/biodermol.tn

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biodermol Ambiente